A Study to Evaluate DEP114 for the Treatment of Acute Exacerbation of Persistent Allergic Rhinitis in Children Aged 6 to Under 12 Years

by | Sep 22, 2026 | Clinical Trials | 0 comments

​ Conditions: Persistent Allergic Rhinitis

Interventions: Drug: DEP114; Drug: Desloratadine

Sponsors: EMS

Not yet recruiting Conditions: Persistent Allergic Rhinitis
Interventions: Drug: DEP114; Drug: Desloratadine
Sponsors: EMS
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *